Hiromatsu Kenji, Dascher Christopher C, LeClair Kenneth P, Sugita Masahiko, Furlong Stephen T, Brenner Michael B, Porcelli Steven A
Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA 02115, USA.
J Immunol. 2002 Jul 1;169(1):330-9. doi: 10.4049/jimmunol.169.1.330.
Group 1 CD1 molecules have been shown to present lipid and glycolipid Ags of mycobacteria to human T cells. However, a suitable animal model for the investigation of this component of antimycobacterial immunity has not yet been established. Previously, we found that guinea pigs express multiple isoforms of group 1 CD1 proteins that are homologous to human CD1b and CD1c. In this study, we show that CD1-restricted T cell responses can be generated in guinea pigs following immunization with lipid Ags from Mycobacterium tuberculosis. Splenic T cells from lipid Ag-immunized guinea pigs showed strong proliferative responses to total lipid Ags and partially purified glycolipid fractions from M. tuberculosis. These lipid Ag-reactive T cells were enriched in CD4-negative T cell fractions and showed cytotoxic activity against CD1-expressing guinea pig bone marrow-derived dendritic cells pulsed with M. tuberculosis lipid Ags. Using guinea pig cell lines transfected with individual CD1 isoforms as target cells in cytotoxic T cell assays, we found that guinea pig CD1b and CD1c molecules presented M. tuberculosis glycolipid Ags to T cells raised by mycobacterial lipid immunization. These results were confirmed using a T cell line derived from M. tuberculosis lipid Ag-immunized guinea pigs, which also showed CD1-restricted responses and cytolytic activity. Our results demonstrate that CD1-restricted responses against microbial glycolipid Ags can be generated in vivo by specific immunization and provide support for the use of the guinea pig as a relevant small animal model for the study of CD1-restricted immune responses to mycobacterial pathogens.
1类CD1分子已被证明可将分枝杆菌的脂质和糖脂抗原呈递给人类T细胞。然而,用于研究抗分枝杆菌免疫这一组成部分的合适动物模型尚未建立。此前,我们发现豚鼠表达与人类CD1b和CD1c同源的多种1类CD1蛋白异构体。在本研究中,我们表明,用结核分枝杆菌的脂质抗原免疫豚鼠后,可在豚鼠体内产生CD1限制性T细胞反应。来自脂质抗原免疫豚鼠的脾T细胞对结核分枝杆菌的总脂质抗原和部分纯化的糖脂组分表现出强烈的增殖反应。这些脂质抗原反应性T细胞在CD4阴性T细胞组分中富集,并对用结核分枝杆菌脂质抗原脉冲处理的表达CD1的豚鼠骨髓来源的树突状细胞具有细胞毒性活性。在细胞毒性T细胞试验中,使用转染了单个CD1异构体的豚鼠细胞系作为靶细胞,我们发现豚鼠CD1b和CD1c分子将结核分枝杆菌糖脂抗原呈递给由分枝杆菌脂质免疫产生的T细胞。使用来自结核分枝杆菌脂质抗原免疫豚鼠的T细胞系证实了这些结果,该细胞系也表现出CD1限制性反应和溶细胞活性。我们的结果表明,通过特异性免疫可在体内产生针对微生物糖脂抗原的CD1限制性反应,并为将豚鼠用作研究针对分枝杆菌病原体的CD1限制性免疫反应的相关小型动物模型提供了支持。